ILUVIEN (Fluocinolone acetonide 190 micrograms intravitreal implant in applicator)
Indicated for the treatment of vision impairment associated with chronic diabetic macular edema (DME), considered insufficiently responsive to available therapies


View Summary of Product Characteristics (SmPC) and  Patient Information Leaflet (PIL)
17NewCountries
ILUVIEN has been granted market authorization in
17
Countries in Europe
Austria, Belgium, the Czech Republic, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Spain, Sweden and the United Kingdom
4NewCountries
ILUVIEN is currently available in
4
countries
For more information Contact us